Connection

Shikhar Mehrotra to Animals

This is a "connection" page, showing publications Shikhar Mehrotra has written about Animals.
Connection Strength

0.938
  1. Pro-Survival Lipid Sphingosine-1-Phosphate Metabolically Programs T Cells to Limit Anti-tumor Activity. Cell Rep. 2019 08 13; 28(7):1879-1893.e7.
    View in: PubMed
    Score: 0.052
  2. Thioredoxin-1 improves the immunometabolic phenotype of antitumor T cells. J Biol Chem. 2019 06 07; 294(23):9198-9212.
    View in: PubMed
    Score: 0.050
  3. Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response. Clin Cancer Res. 2019 02 01; 25(3):1036-1049.
    View in: PubMed
    Score: 0.049
  4. CD38-NAD+Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response. Cell Metab. 2018 01 09; 27(1):85-100.e8.
    View in: PubMed
    Score: 0.046
  5. Replenishing Regulatory T Cells to Halt?Depigmentation in Vitiligo. J Investig Dermatol Symp Proc. 2017 10; 18(2):S38-S45.
    View in: PubMed
    Score: 0.045
  6. Blocking TCR restimulation induced necroptosis in adoptively transferred T cells improves tumor control. Oncotarget. 2016 Oct 25; 7(43):69371-69383.
    View in: PubMed
    Score: 0.042
  7. Lack of p53 Augments Antitumor Functions in Cytolytic T Cells. Cancer Res. 2016 09 15; 76(18):5229-5240.
    View in: PubMed
    Score: 0.042
  8. Reducing CD73 expression by IL1?-Programmed Th17 cells improves immunotherapeutic control of tumors. Cancer Res. 2014 Nov 01; 74(21):6048-59.
    View in: PubMed
    Score: 0.037
  9. Interferon-gamma (IFN-?)-mediated retinal ganglion cell death in human tyrosinase T cell receptor transgenic mouse. PLoS One. 2014; 9(2):e89392.
    View in: PubMed
    Score: 0.035
  10. A quantitative increase in regulatory T cells controls development of vitiligo. J Invest Dermatol. 2014 May; 134(5):1285-1294.
    View in: PubMed
    Score: 0.035
  11. Redox regulation of T-cell function: from molecular mechanisms to significance in human health and disease. Antioxid Redox Signal. 2013 Apr 20; 18(12):1497-534.
    View in: PubMed
    Score: 0.032
  12. A coreceptor-independent transgenic human TCR mediates anti-tumor and anti-self immunity in mice. J Immunol. 2012 Aug 15; 189(4):1627-38.
    View in: PubMed
    Score: 0.032
  13. Oxidative stress and lymphocyte persistence: implications in immunotherapy. Adv Cancer Res. 2009; 102:197-227.
    View in: PubMed
    Score: 0.025
  14. Crosstalk between pro-survival sphingolipid metabolism and complement signaling induces inflammasome-mediated tumor metastasis. Cell Rep. 2022 12 06; 41(10):111742.
    View in: PubMed
    Score: 0.016
  15. Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8+ T Cells. Cancer Res. 2022 07 18; 82(14):2640-2655.
    View in: PubMed
    Score: 0.016
  16. Modulating donor mitochondrial fusion/fission delivers immunoprotective effects in cardiac transplantation. Am J Transplant. 2022 02; 22(2):386-401.
    View in: PubMed
    Score: 0.015
  17. Hematopoietic stem cell-derived functional osteoblasts exhibit therapeutic efficacy in a murine model of osteogenesis imperfecta. Stem Cells. 2021 11; 39(11):1457-1477.
    View in: PubMed
    Score: 0.015
  18. Aging-dependent mitochondrial dysfunction mediated by ceramide signaling inhibits antitumor T?cell response. Cell Rep. 2021 05 04; 35(5):109076.
    View in: PubMed
    Score: 0.015
  19. Changes in Class I and IIb HDACs by d-Opioid in Chronic Rat Glaucoma Model. Invest Ophthalmol Vis Sci. 2020 12 01; 61(14):4.
    View in: PubMed
    Score: 0.014
  20. Antigen Specificity Enhances Disease Control by Tregs in Vitiligo. Front Immunol. 2020; 11:581433.
    View in: PubMed
    Score: 0.014
  21. Histone Deacetylases Regulation by d-Opioids in Human Optic Nerve Head Astrocytes. Invest Ophthalmol Vis Sci. 2020 09 01; 61(11):17.
    View in: PubMed
    Score: 0.014
  22. CD38: T Cell Immuno-Metabolic Modulator. Cells. 2020 07 17; 9(7).
    View in: PubMed
    Score: 0.014
  23. The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling. Immunity. 2020 04 14; 52(4):668-682.e7.
    View in: PubMed
    Score: 0.014
  24. Development of a Novel Humanized Monoclonal Antibody to Secreted Frizzled-Related Protein-2 That Inhibits Triple-Negative Breast Cancer and Angiosarcoma Growth In Vivo. Ann Surg Oncol. 2019 Dec; 26(13):4782-4790.
    View in: PubMed
    Score: 0.013
  25. Thioredoxin-1 confines T cell alloresponse and pathogenicity in graft-versus-host disease. J Clin Invest. 2019 05 02; 129(7):2760-2774.
    View in: PubMed
    Score: 0.013
  26. ER stress-induced mediator C/EBP homologous protein thwarts effector T?cell activity in tumors through T-bet repression. Nat Commun. 2019 03 20; 10(1):1280.
    View in: PubMed
    Score: 0.013
  27. Targeting Sirt-1 controls GVHD by inhibiting T-cell allo-response and promoting Treg stability in mice. Blood. 2019 01 17; 133(3):266-279.
    View in: PubMed
    Score: 0.012
  28. CAR T Cells in Solid Tumors: Blueprints for Building Effective Therapies. Front Immunol. 2018; 9:1740.
    View in: PubMed
    Score: 0.012
  29. Impact of Mitochondrial Permeability on Endothelial Cell Immunogenicity in Transplantation. Transplantation. 2018 06; 102(6):935-944.
    View in: PubMed
    Score: 0.012
  30. Hematopoietic Stem Cells as a Novel Source of Dental Tissue Cells. Sci Rep. 2018 05 23; 8(1):8026.
    View in: PubMed
    Score: 0.012
  31. PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity. J Clin Invest. 2018 07 02; 128(7):2787-2801.
    View in: PubMed
    Score: 0.012
  32. Enhanced Lymphodepletion Is Insufficient to Replace Exogenous IL2 or IL15 Therapy in Augmenting the Efficacy of Adoptively Transferred Effector CD8+ T Cells. Cancer Res. 2018 06 01; 78(11):3067-3074.
    View in: PubMed
    Score: 0.012
  33. IL-2 and Beyond in Cancer Immunotherapy. J Interferon Cytokine Res. 2018 02; 38(2):45-68.
    View in: PubMed
    Score: 0.012
  34. S-Glutathionylation of estrogen receptor a affects dendritic cell function. J Biol Chem. 2018 03 23; 293(12):4366-4380.
    View in: PubMed
    Score: 0.012
  35. Targeting the PIM protein kinases for the treatment of a T-cell acute lymphoblastic leukemia subset. Oncotarget. 2017 May 02; 8(18):30199-30216.
    View in: PubMed
    Score: 0.011
  36. Efficacy of Adoptive T-cell Therapy Is Improved by Treatment with the Antioxidant N-Acetyl Cysteine, Which Limits Activation-Induced T-cell Death. Cancer Res. 2016 10 15; 76(20):6006-6016.
    View in: PubMed
    Score: 0.011
  37. Ccl22 Diverts T Regulatory Cells and Controls the Growth of Melanoma. Cancer Res. 2016 11 01; 76(21):6230-6240.
    View in: PubMed
    Score: 0.011
  38. Metabolic reprogramming of alloantigen-activated T cells after hematopoietic cell transplantation. J Clin Invest. 2016 Apr 01; 126(4):1337-52.
    View in: PubMed
    Score: 0.010
  39. IL-2Ra mediates temporal regulation of IL-2 signaling and enhances immunotherapy. Sci Transl Med. 2015 Oct 28; 7(311):311ra170.
    View in: PubMed
    Score: 0.010
  40. Effector CD8+ T-cell Engraftment and Antitumor Immunity in Lymphodepleted Hosts Is IL7Ra Dependent. Cancer Immunol Res. 2015 Dec; 3(12):1364-74.
    View in: PubMed
    Score: 0.010
  41. IL-12 conditioning improves retrovirally mediated transduction efficiency of CD8+ T cells. Cancer Gene Ther. 2015 Jul; 22(7):360-7.
    View in: PubMed
    Score: 0.010
  42. Interleukin-12 enhances the function and anti-tumor activity in murine and human CD8(+) T cells. Cancer Immunol Immunother. 2015 May; 64(5):539-49.
    View in: PubMed
    Score: 0.009
  43. The inducible costimulator augments Tc17 cell responses to self and tumor tissue. J Immunol. 2015 Feb 15; 194(4):1737-47.
    View in: PubMed
    Score: 0.009
  44. CCL22 to Activate Treg Migration and Suppress Depigmentation in Vitiligo. J Invest Dermatol. 2015 Jun; 135(6):1574-1580.
    View in: PubMed
    Score: 0.009
  45. Deletion of Pim kinases elevates the cellular levels of reactive oxygen species and sensitizes to K-Ras-induced cell killing. Oncogene. 2015 Jul; 34(28):3728-36.
    View in: PubMed
    Score: 0.009
  46. Immune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentation. Pigment Cell Melanoma Res. 2014 Nov; 27(6):1075-85.
    View in: PubMed
    Score: 0.009
  47. Mutant HSP70 reverses autoimmune depigmentation in vitiligo. Sci Transl Med. 2013 Feb 27; 5(174):174ra28.
    View in: PubMed
    Score: 0.008
  48. Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1-phosphate signalling to regulate tumour metastasis. EMBO Mol Med. 2012 Aug; 4(8):761-75.
    View in: PubMed
    Score: 0.008
  49. Cross-presentation of a human tumor antigen delivered to dendritic cells by HSV VP22-mediated protein translocation. Eur J Immunol. 2004 Oct; 34(10):2824-33.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.